跳至主要内容
临床试验/EUCTR2006-000348-26-GB
EUCTR2006-000348-26-GB进行中(未招募)1 期

A randomised prospective study to investigate the efficacy of corneal collagen cross-linkage with riboflavin (vitamin B2) and ultraviolet A light (UVA) (370nm) to halt the progression of keratoconus. - UVA/B2

Guy's & St Thomas' NHS Foundation Trust0 个研究点目标入组 36 人开始时间: 2006年4月21日最近更新:

试验速览

阶段
1 期
状态
进行中(未招募)
发起方
入组人数
36

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
All

入选标准

  • Age 18 to 70
  • Must fully understand the investigative nature of the study
  • Moderate to advanced bilateral keratoconus
  • No known allergies to pre- and post-operative medications
  • Willingness to attend for follow-up examinations
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range
  • F.1.3 Elderly (>=65 years) yes
  • F.1.3.1 Number of subjects for this age range

排除标准

  • Age below 18
  • Other pre-existing ophthalmic pathology
  • Previous ophthalmic surgeryUnilateral keratoconus
  • Severe keratoconus in which the cornea is so distorted that accurate refractive and corneal measurements cannot be obtained (in these eyes data confirming stability or progression is not possible)

研究者

发起方
Guy's & St Thomas' NHS Foundation Trust

相似试验